First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions

Nature Reviews Drug Discovery 2026

View at publisher

Authors: Asher Mullard

DOI: 10.1038/d41573-026-00078-6

Cited by: 6

Fields of Study & Subjects

Protein Degradation and Inhibitors HER2/EGFR in Cancer Research Click Chemistry and Applications